Seres Therapeutics
MCRB
#10246
Rank
C$4.51 M
Marketcap
$0.52
Share price
1.11%
Change (1 day)
-58.44%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -C$0.18 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.19 Billion34.63%
2023 -C$0.14 Billion-59.97%
2022 -C$0.34 Billion289.57%
2021 -C$86.68 Million-27.3%
2020 -C$0.12 Billion23%
2019 -C$96.94 Million-30.11%
2018 -C$0.14 Billion9.73%
2017 -C$0.13 Billion-0.74%
2016 -C$0.13 Billion70.96%
2015 -C$74.5 Million257.11%
2014 -C$20.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.34 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.36 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.59 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA